What is the current Viscosupplementation Injection market size?

The Viscosupplementation Injection market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Viscosupplementation Injection market?

Key drivers include rising osteoarthritis cases and growing demand for non-surgical treatments.

What are the major challenges facing the Viscosupplementation Injection market?

Challenges include high treatment costs and limited reimbursement coverage in some regions.

Which regions are leading the Viscosupplementation Injection market?

North America and Europe are leading the market due to high healthcare expenditure.

Who are the top companies in the Viscosupplementation Injection market?

Top companies include Sanofi, Johnson & Johnson, and Anika Therapeutics, among others.

What are the future opportunities in the Viscosupplementation Injection market?

Future opportunities include emerging markets and advancements in injection technologies.

How is technology impacting the Viscosupplementation Injection market?

Advances in injection devices and hyaluronic acid products are improving treatment outcomes.

What is the current regulatory landscape for the Viscosupplementation Injection market?

The market is regulated by authorities such as the FDA and EMA, ensuring product safety and efficacy.

What is the future outlook for the Viscosupplementation Injection market?

The future outlook is positive, driven by increasing adoption of viscosupplementation injections.

Viscosupplementation Injection Growth Drivers & Forecast Analysis 2033

Viscosupplementation Injection by Application (Hospitals, Clinics, Others), by Types (Single Injection, Three Injection, Five Injection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $1240 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $1240 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Viscosupplementation Injection Market Overview

The Viscosupplementation Injection market refers to the industry that provides injectable treatments for osteoarthritis and other joint-related disorders. As a crucial aspect of the global healthcare landscape, the Viscosupplementation Injection market size is estimated to be around $3.8 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $6.3 billion by 2033, driven by an increasing demand for non-surgical treatments for joint pain. The industry expansion is expected to be fueled by advancements in technology, rising awareness about the benefits of viscosupplementation, and an growing geriatric population. The scope of this market encompasses various types of injections, including hyaluronic acid, synthetic, and natural injections, used in applications such as osteoarthritis, tendonitis, and ligament sprains.

Loading chart…

The Viscosupplementation Injection market is expected to grow at a CAGR of 7.8% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of osteoarthritis, rising demand for minimally invasive procedures, and advancements in injection technologies. Key forces shaping the industry include technology shifts towards more effective and longer-lasting injections, regulatory requirements for product approvals, and consumer behavior trends towards preventive care. The largest region in the Viscosupplementation Injection market is North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by increasing healthcare expenditure and a growing geriatric population. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, opportunities, and challenges to make strategic decisions and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	1.24 billion
Revenue forecast in 2033	2.33 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sanofi; Anika Therapeutics; Seikagaku; Zimmer Biomet; Bioventus; Ferring; LG Chem; Freda; Haohai Biological; Shanghai Jingfeng
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Viscosupplementation Injection market is poised for significant growth, driven by an increasing prevalence of osteoarthritis and a growing demand for non-surgical treatment options. The market dynamics are shaped by various factors, including technological advancements, regulatory approvals, and shifting consumer preferences.

Growth Drivers2 items

Advances in Viscosupplementation Injection technology, such as the development of more effective and longer-lasting hyaluronic acid-based products, are expected to drive market growth and increase the Viscosupplementation Injection market size.

An aging population and rising obesity rates are contributing to an increase in osteoarthritis cases, fuelling demand for Viscosupplementation Injection treatments and supporting a positive growth forecast.

Restraints2 items

High costs associated with Viscosupplementation Injection treatments and limited reimbursement options in some regions may hinder market growth and impact the overall Viscosupplementation Injection market size.

Stringent regulatory requirements and varying approval processes across different countries can slow down the introduction of new Viscosupplementation Injection products, affecting the market's growth forecast.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer significant growth opportunities for Viscosupplementation Injection manufacturers, driven by an increasing demand for non-surgical osteoarthritis treatments and a rising Viscosupplementation Injection market size.

The development of combination therapies, such as Viscosupplementation Injection with platelet-rich plasma or corticosteroids, can provide new revenue streams and enhance the growth forecast for market players.

Challenges2 items

Intense competition among Viscosupplementation Injection manufacturers, particularly in the hyaluronic acid-based product segment, can lead to pricing pressures and reduced profit margins, impacting the overall Viscosupplementation Injection market size.

Ensuring the quality and safety of Viscosupplementation Injection products, while also complying with evolving regulatory requirements, poses a significant challenge for manufacturers and can affect their ability to achieve a positive growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Viscosupplementation Injection market refers to the various uses of these injections in treating different joint-related disorders. This segment is crucial in understanding the Viscosupplementation Injection segmentation as it directly impacts the market size. The application segment can be further divided into subtypes, including osteoarthritis of the knee, hip, and other joints. Each subtype contributes to the overall market size, with osteoarthritis of the knee being the most prominent application.

The Types segment of the Viscosupplementation Injection market encompasses the different types of injections available, including hyaluronic acid, synthetic, and autologous injections. This segment plays a significant role in determining the market taxonomy of the Viscosupplementation Injection market. The types segment is vital in understanding the market landscape, as each type has its own set of advantages and disadvantages, affecting the overall market size. For instance, hyaluronic acid injections are the most widely used type, driving the market growth.

Viscosupplementation Injection Segmentation Breakdown8 items

Application

Hospitals

Clinics

Others

Types

Single Injection

Three Injection

Five Injection

Regional Insights

Loading chart…

The Viscosupplementation Injection market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of viscosupplementation injections, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by a strong ecosystem maturity, favorable policies, and a large patient population. Asia Pacific is fueled by increasing adoption, rising investments, and growing demographics. Latin America and Middle East & Africa are driven by improving infrastructure, growing demographics, and increasing adoption.

The regional forecast indicates that Asia Pacific will experience the highest Viscosupplementation Injection market growth rate, driven by the increasing adoption of viscosupplementation injections and growing demographics. North America and Europe will maintain their market share, while Latin America and Middle East & Africa will experience moderate growth.

Competitive Landscape

The Viscosupplementation Injection market is moderately consolidated, with a mix of global players and local companies competing for market share. The Viscosupplementation Injection competitive landscape is driven by key competitive levers such as pricing, distribution, and product innovation. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are leveraging their regional presence and cost advantages to compete.

Companies in the Viscosupplementation Injection market are adopting various strategies to differentiate themselves, including M&A, partnerships, and product launches. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies need to focus on technology, service model, and channel strength. The following companies are implementing different strategies to stay ahead in the market:

Sanofi: regional expansion

Anika Therapeutics: innovation pipeline

Seikagaku: premium pricing

Zimmer Biomet: OEM tie-ups

Bioventus: local manufacturing

Ferring: vertical integration

Key Viscosupplementation Injection Companies10 items

Sanofi

Anika Therapeutics

Seikagaku

Zimmer Biomet

Bioventus

Ferring

LG Chem

Freda

Haohai Biological

Shanghai Jingfeng

Market Ecosystem

The Viscosupplementation Injection ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of viscosupplementation injections. The ecosystem boundaries are defined by the interactions between these participants, influencing the overall efficiency and effectiveness of the value chain analysis.

Raw material suppliers — providing hyaluronic acid and other components

OEMs / manufacturers — producing viscosupplementation injections

Distributors / channel partners — delivering products to healthcare providers

Service providers / after-sales — offering support and training

End users / buyers — healthcare providers and patients

Regulators/standards bodies — overseeing safety and efficacy

Data/analytics providers — supplying market insights and research

The flow of value within the Viscosupplementation Injection ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact adoption rates. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements may vary across different regions, leading to diverse ecosystem dynamics. Understanding these complexities is essential for navigating the Viscosupplementation Injection ecosystem and identifying opportunities for growth and improvement.

Recent Industry Insights

The Viscosupplementation Injection industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between major pharmaceutical companies and research institutions, have driven innovation in the field. Additionally, mergers and acquisitions have led to market consolidation, enabling companies to expand their product portfolios and strengthen their market presence. Furthermore, the launch of new products and technologies has improved treatment options for patients, while regulatory changes have ensured stricter safety and efficacy standards.

The shift in consumer trends towards minimally invasive procedures has also fueled demand for viscosupplementation injections. Moreover, funding rounds and expansions have enabled companies to invest in research and development, driving growth in the market. As the industry continues to evolve, it is essential to stay informed about the latest Viscosupplementation Injection industry trends to capitalize on emerging opportunities and stay ahead of the competition.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Viscosupplementation Injection market outlook. The market attractiveness is moderate, driven by an aging population and increasing demand for non-surgical treatments for osteoarthritis. The competitive intensity is high, with several key players vying for market share. In the long term, the market is expected to grow, driven by advancements in technology and an increasing focus on minimally invasive procedures.

The innovation landscape is rapidly evolving, with a focus on developing more effective and longer-lasting treatments. The demand-supply balance is currently stable, but may be disrupted by changes in regulatory policies or the introduction of new products. Key risk factors include regulatory scrutiny and reimbursement pressures. Overall, the Viscosupplementation Injection market is expected to experience steady growth, driven by an increasing demand for effective treatments for osteoarthritis.

12 items

1. Executive Summary

2. Viscosupplementation Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Viscosupplementation Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Viscosupplementation Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Viscosupplementation Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Viscosupplementation Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Viscosupplementation Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Viscosupplementation Injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Viscosupplementation Injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Viscosupplementation Injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Viscosupplementation Injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Viscosupplementation Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Viscosupplementation Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Viscosupplementation Injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Viscosupplementation Injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Viscosupplementation Injection Market Competition by Key Manufacturers

9.1. Global Viscosupplementation Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Viscosupplementation Injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sanofi

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Anika Therapeutics

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Seikagaku

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Zimmer Biomet

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bioventus

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Ferring

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. LG Chem

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Freda

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Haohai Biological

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shanghai Jingfeng

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Viscosupplementation Injection Market

Figure 4: Global Viscosupplementation Injection Market: Drivers

Figure 5: Global Viscosupplementation Injection Market: Challenges

Figure 6: Global Viscosupplementation Injection Market: Trends

Figure 7: Global Viscosupplementation Injection Market: Opportunity

Figure 8: Global Viscosupplementation Injection Market: Restraint

Figure 9: Global Viscosupplementation Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Viscosupplementation Injection Market Value (USD Million) By Region

Figure 19: Global Viscosupplementation Injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Viscosupplementation Injection Market Value (USD Million) By Region

Figure 27: Global Viscosupplementation Injection Market Share (%) By: Regions (2032)

Figure 28: Global Viscosupplementation Injection Market Volume (K) By Region

Figure 29: Global Viscosupplementation Injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Viscosupplementation Injection Market Value (USD Million) By Region

Figure 37: Global Viscosupplementation Injection Market Share (%) By: Regions (2032)

Figure 38: Global Viscosupplementation Injection Market Volume (K) By Region

Figure 39: Global Viscosupplementation Injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Viscosupplementation Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Viscosupplementation Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Viscosupplementation Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Viscosupplementation Injection Market Value (USD Million) By Region

Table 14: Global Viscosupplementation Injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Viscosupplementation Injection Market Volume (K) By Region

Table 31: Global Viscosupplementation Injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Viscosupplementation Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Viscosupplementation Injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Viscosupplementation Injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sanofi Basic Information And Sales Area

Table 52: Sanofi. Products Portfolio

Table 53: Anika Therapeutics Basic Information And Sales Area

Table 54: Anika Therapeutics. Products Portfolio

Table 55: Seikagaku Basic Information And Sales Area

Table 56: Seikagaku. Products Portfolio

Table 57: Zimmer Biomet Basic Information And Sales Area

Table 58: Zimmer Biomet. Products Portfolio

Table 59: Bioventus Basic Information And Sales Area

Table 60: Bioventus. Products Portfolio

Table 61: Ferring Basic Information And Sales Area

Table 62: Ferring. Products Portfolio

Table 63: LG Chem Basic Information And Sales Area

Table 64: LG Chem. Products Portfolio

Table 65: Freda Basic Information And Sales Area

Table 66: Freda. Products Portfolio

Table 67: Haohai Biological Basic Information And Sales Area

Table 68: Haohai Biological. Products Portfolio

Table 69: Shanghai Jingfeng Basic Information And Sales Area

Table 70: Shanghai Jingfeng. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Viscosupplementation Injection Market Value (USD Million) By Region

Table 80: Global Viscosupplementation Injection Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Viscosupplementation Injection Market Volume (K) By Region

Table 97: Global Viscosupplementation Injection Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Viscosupplementation Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.24 billion
Revenue forecast in 2033	2.33 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sanofi; Anika Therapeutics; Seikagaku; Zimmer Biomet; Bioventus; Ferring; LG Chem; Freda; Haohai Biological; Shanghai Jingfeng
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Viscosupplementation Injection Segmentation Breakdown8 items

Application

Hospitals

Clinics

Others

Types

Single Injection

Three Injection

Five Injection

Regional Insights

Loading chart…

Competitive Landscape

Sanofi: regional expansion

Anika Therapeutics: innovation pipeline

Seikagaku: premium pricing

Zimmer Biomet: OEM tie-ups

Bioventus: local manufacturing

Ferring: vertical integration

Key Viscosupplementation Injection Companies10 items

Sanofi

Anika Therapeutics

Seikagaku

Zimmer Biomet

Bioventus

Ferring

LG Chem

Freda

Haohai Biological

Shanghai Jingfeng

Market Ecosystem

Raw material suppliers — providing hyaluronic acid and other components

OEMs / manufacturers — producing viscosupplementation injections

Distributors / channel partners — delivering products to healthcare providers

Service providers / after-sales — offering support and training

End users / buyers — healthcare providers and patients

Regulators/standards bodies — overseeing safety and efficacy

Data/analytics providers — supplying market insights and research

Recent Industry Insights

Analyst Overview

Table of Contents